Ordinary Adjustment | Solactive Global Vaccines and Infectious Diseases Index CNTR | Effective Date 17th November 2025
Solactive Global Vaccines and Infectious Diseases Index CNTR:
In the ordinary adjustment, the following composition will be implemented effective open 17th November 2025:
| AB&B BIO-TECH-B ORD H |
| ABBVIE INC |
| ABCELLERA BIOLOGICS INC |
| ADMA BIOLOGICS INC |
| ASTRAZENECA PLC |
| BAVARIAN NORDIC A/S |
| BIONTECH SE |
| BRISTOL-MYERS SQUIBB CO |
| CIDARA THERAPEUTICS INC |
| CUREVAC BV |
| DENKA CO LTD |
| DYNAVAX TECHNOLOGIES CORP |
| GILEAD SCIENCES INC |
| GREEN CROSS CORP ORD |
| GSK PLC |
| IMMUNITYBIO INC |
| JOHNSON & JOHNSON |
| LIVZON PHARMACEUTICAL GROUP INC |
| MERCK & CO. INC. |
| MODERNA INC |
| NOVAVAX INC |
| OPKO HEALTH INC |
| PFIZER INC |
| REGENERON PHARMACEUTICALS |
| SANOFI SA |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD |
| SK BIOSCIENCE ORD |
| TG THERAPEUTICS INC |
| VAXCYTE INC |
| ZOETIS INC |